Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison M Ivey

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of the National Cancer Institute|December 6, 2014
Clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastomaFrederic J Kaye, Alison M Ivey, Walter E Drane, et al.
Journal of the National Cancer Institute|September 28, 2016
ResponseFrederic J Kaye, Alison M Ivey, Walter E Drane, et al.
Cancer Medicine|March 14, 2015
Multidisciplinary neoadjuvant management for potentially curable pancreatic cancerNeelam V Desai, Sarunas Sliesoraitis, Steven J Hughes, et al.
Oncotarget|January 17, 2019
CDK4/6 inhibition stabilizes disease in patients with p16-null non-small cell lung cancer and is synergistic with mTOR inhibitionPriya K Gopalan, Andres Gordillo Villegas, Chunxia Cao, et al.
The Oncologist|January 29, 2021
Activity of Sorafenib Plus Capecitabine in Previously Treated Metastatic Colorectal CancerThomas J George, Alison M Ivey, Azka Ali, et al.
The Oncologist|June 8, 2021
Phase II Study of 5-Fluorouracil, Oxaliplatin plus Dasatinib (FOLFOX-D) in First-Line Metastatic Pancreatic AdenocarcinomaThomas J George, Azka Ali, Yu Wang, et al.
Journal of Medical Case Reports|February 1, 2012
Response to sunitinib in combination with proton beam radiation in a patient with chondrosarcoma: a case reportJennifer Dallas, Iman Imanirad, Rajiv Rajani, et al.
Oncology|November 17, 2011
Combination therapy for renal cell cancer: what are possible options?Napoleon Santos, Justin B Wenger, Pamela Havre, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of the National Cancer Institute|December 6, 2014
Clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastomaFrederic J Kaye, Alison M Ivey, Walter E Drane, et al.
Journal of the National Cancer Institute|September 28, 2016
ResponseFrederic J Kaye, Alison M Ivey, Walter E Drane, et al.
Cancer Medicine|March 14, 2015
Multidisciplinary neoadjuvant management for potentially curable pancreatic cancerNeelam V Desai, Sarunas Sliesoraitis, Steven J Hughes, et al.
Oncotarget|January 17, 2019
CDK4/6 inhibition stabilizes disease in patients with p16-null non-small cell lung cancer and is synergistic with mTOR inhibitionPriya K Gopalan, Andres Gordillo Villegas, Chunxia Cao, et al.
The Oncologist|January 29, 2021
Activity of Sorafenib Plus Capecitabine in Previously Treated Metastatic Colorectal CancerThomas J George, Alison M Ivey, Azka Ali, et al.
The Oncologist|June 8, 2021
Phase II Study of 5-Fluorouracil, Oxaliplatin plus Dasatinib (FOLFOX-D) in First-Line Metastatic Pancreatic AdenocarcinomaThomas J George, Azka Ali, Yu Wang, et al.
Journal of Medical Case Reports|February 1, 2012
Response to sunitinib in combination with proton beam radiation in a patient with chondrosarcoma: a case reportJennifer Dallas, Iman Imanirad, Rajiv Rajani, et al.
Oncology|November 17, 2011
Combination therapy for renal cell cancer: what are possible options?Napoleon Santos, Justin B Wenger, Pamela Havre, et al.
Pageof 1